EDE has issued Pharmacovigilance Practice Guideline for Medical Products
According to Resolution No. (27) of 2026, published by the Emirates Drug
According to Resolution No. (27) of 2026, published by the Emirates Drug
SFDA has issued a new regulatory guide clarifying the services and requirements
SFDA has published six guidelines regarding classification of violations and associated penalties
OMAN MOH issued new Circular No. 51/2026 – Suspension of Receiving Medicines
NHRA has updated three key pharmaceutical regulatory guidelines in Bahrain as part
OMAN MOH issued new Circular No. 45/2026 – Adherence to Procuring Medicines
OMAN MOH issued new Circular No. 35/2026 introducing updated restrictions on the
Saudi Food and Drug Authority (SFDA) has issued Version 1.0 of new
SFDA has issued Version 2.0 of the “Guidance for Combination Products Classification
SFDA has issued Version 9.0 of the “Products Classification Guidance”, introducing updated